Skip to main content
Journal cover image

HIV and women in the USA: what we know and where to go from here.

Publication ,  Journal Article
Adimora, AA; Ramirez, C; Poteat, T; Archin, NM; Averitt, D; Auerbach, JD; Agwu, AL; Currier, J; Gandhi, M
Published in: Lancet (London, England)
March 2021

New diagnoses of HIV infection have decreased among women in the USA overall, but marked racial and geographical disparities persist. The federal government has announced an initiative that aims to decrease the number of new infections in the nation by 90% within the next 10 years. With this in mind, we highlight important recent developments concerning HIV epidemiology, comorbidities, treatment, and prevention among women in the USA. We conclude that, to end the US HIV epidemic, substantially greater inclusion of US women in clinical research will be required, as will better prevention and treatment efforts, with universal access to health care and other supportive services that enable women to exercise agency in their own HIV prevention and care. Ending the epidemic will also require eliminating the race, class, and gender inequities, as well as the discrimination and structural violence, that have promoted and maintained the distribution of HIV in the USA, and that will, if unchecked, continue to fuel the epidemic in the future.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Lancet (London, England)

DOI

EISSN

1474-547X

ISSN

0140-6736

Publication Date

March 2021

Volume

397

Issue

10279

Start / End Page

1107 / 1115

Related Subject Headings

  • Young Adult
  • United States
  • Transgender Persons
  • Sexism
  • Prevalence
  • Humans
  • Healthcare Disparities
  • Health Status Disparities
  • Health Services Accessibility
  • HIV Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Adimora, A. A., Ramirez, C., Poteat, T., Archin, N. M., Averitt, D., Auerbach, J. D., … Gandhi, M. (2021). HIV and women in the USA: what we know and where to go from here. Lancet (London, England), 397(10279), 1107–1115. https://doi.org/10.1016/s0140-6736(21)00396-2
Adimora, Adaora A., Catalina Ramirez, Tonia Poteat, Nancie M. Archin, Dawn Averitt, Judith D. Auerbach, Allison L. Agwu, Judith Currier, and Monica Gandhi. “HIV and women in the USA: what we know and where to go from here.Lancet (London, England) 397, no. 10279 (March 2021): 1107–15. https://doi.org/10.1016/s0140-6736(21)00396-2.
Adimora AA, Ramirez C, Poteat T, Archin NM, Averitt D, Auerbach JD, et al. HIV and women in the USA: what we know and where to go from here. Lancet (London, England). 2021 Mar;397(10279):1107–15.
Adimora, Adaora A., et al. “HIV and women in the USA: what we know and where to go from here.Lancet (London, England), vol. 397, no. 10279, Mar. 2021, pp. 1107–15. Epmc, doi:10.1016/s0140-6736(21)00396-2.
Adimora AA, Ramirez C, Poteat T, Archin NM, Averitt D, Auerbach JD, Agwu AL, Currier J, Gandhi M. HIV and women in the USA: what we know and where to go from here. Lancet (London, England). 2021 Mar;397(10279):1107–1115.
Journal cover image

Published In

Lancet (London, England)

DOI

EISSN

1474-547X

ISSN

0140-6736

Publication Date

March 2021

Volume

397

Issue

10279

Start / End Page

1107 / 1115

Related Subject Headings

  • Young Adult
  • United States
  • Transgender Persons
  • Sexism
  • Prevalence
  • Humans
  • Healthcare Disparities
  • Health Status Disparities
  • Health Services Accessibility
  • HIV Infections